Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use Disorder
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 22, 2024 -- Semaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD), according to a study published online Nov. 13 in JAMA Psychiatry.
Markku Lähteenvuo, M.D., Ph.D., from the University of Eastern Finland in Kuopio, and colleagues conducted an observational study in Sweden using data from January 2006 to December 2023 to examine whether the risk for hospitalization due to AUD is decreased during use of glucagon-like peptide-1 (GLP-1) receptor agonists versus nonuse in the same individual. The cohort included 227,866 individuals with AUD, who were followed for a median of 8.8 years.
The researchers found that 58.5 percent of the individuals experienced AUD hospitalization. The lowest risks for AUD and substance use disorder (SUD) hospitalization were seen in association with semaglutide use (adjusted hazard ratios, 0.64 and 0.68 for AUD and any SUD, respectively) and liraglutide use (adjusted hazard ratios, 0.72 and 0.78, respectively). A modestly decreased risk was seen in association with use of any AUD medication (adjusted hazard ratio, 0.98). Reductions in the risk for somatic hospitalizations were also seen in association with semaglutide and liraglutide use (adjusted hazard ratios, 0.78 and 0.79, respectively), but there was no association with suicide attempts.
"AUDs and SUDs are undertreated pharmacologically, despite the availability of effective treatments," the authors write. "GLP-1 agonists, and especially semaglutide and liraglutide, may be effective in the treatment of AUD."
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Young Women Show Greater Increase in Past-Month Binge Drinking Than Men
THURSDAY, April 24, 2025 -- The sex-based differences in past-month binge drinking among young adults reversed in 2021-2023 versus 2017-2019, with higher rates emerging among...
Moderate, Heavy Alcohol Consumption Linked to Signs of Injury in the Brain
FRIDAY, April 11, 2025 -- Moderate, heavy, and former heavy alcohol consumption are associated with hyaline arteriolosclerosis and neurofibrillary tangles, according to a study...
1992 to 2021 Saw Decrease in Burden of Alcohol-Related Cirrhosis in Women
MONDAY, April 7, 2025 -- The burden of alcohol-related cirrhosis (AC) among women has decreased but is disproportionately high in lower Sociodemographic Index (SDI) regions...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.